|
Volumn 38, Issue 10, 2000, Pages 73-75
|
Bupropion to aid smoking cessation
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
AMINE OXIDASE (FLAVIN CONTAINING);
ANTIARRHYTHMIC AGENT;
ANTIDEPRESSANT AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DEBRISOQUINE 4 HYDROXYLASE;
DESIPRAMINE;
DOPAMINE;
DRUG METABOLITE;
FLECAINIDE;
NEUROLEPTIC AGENT;
NICOTINE;
NICOTINE GUM;
NIQUITIN CQ PATCH;
NORADRENALIN;
PAROXETINE;
PLACEBO;
PROPAFENONE;
RISPERIDONE;
SEROTONIN;
THIORIDAZINE;
ARTHRALGIA;
ARTICLE;
BRAIN;
CLINICAL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG CONTRAINDICATION;
DRUG COST;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG RELEASE;
FEVER;
HUMAN;
HYPERTENSION;
IN VITRO STUDY;
INSOMNIA;
MAJOR CLINICAL STUDY;
MYALGIA;
NEUROTRANSMITTER RELEASE;
RANDOMIZED CONTROLLED TRIAL;
RASH;
SEIZURE;
SMOKING CESSATION;
URINARY EXCRETION;
URTICARIA;
WEIGHT GAIN;
XEROSTOMIA;
|
EID: 0033752612
PISSN: 00126543
EISSN: None
Source Type: Journal
DOI: 10.1136/dtb.2000.381073 Document Type: Article |
Times cited : (11)
|
References (18)
|